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BY-NC-ND license (http://creativecomBackground/Purpose: Breast cancer patients in Asia show considerable disparities from Cauca-
sian patients, such as younger age of onset and lower rates of smoking, obesity, and diabetes.
Findings of prior studies regarding risk factors associated with complications in tissue expander
may not hold for Asian populations, since most of these studies involved Caucasian patients. In
this study, we surveyed risk factors in the Taiwanese population, providing additional evidence
about the important differences and discuss the implications for clinical practice.
Methods: Patients who underwent immediate, two-stage, tissue expander breast reconstruc-
tion from December 2008 to August 2014 in the National Taiwan University Hospital, Taipei,
Taiwan were included. Follow-up observations of all patients were conducted until December
2014. Complications occurring during the tissue expander stage were evaluated. Multivariate
regression modeling was used to identify risk factors for complications.
Results: A total of 246 consecutive, immediate, smooth round tissue expander placements
were performed for breast reconstruction. The most common complication was skin necrosis
(4.9%), followed by wound dehiscence (4.1%). In the multivariate model, body mass index
(BMI)  24 kg/m2 was the only risk factor that reached statistical significance (odds ratio:
2.41, 95% confidence interval: 1.17e4.96).
Conclusion: We provided evidence that racial disparities have an impact on the risk factors for
complications associated with tissue expander breast reconstruction. BMI 24 kg/m2 was theave no conflicts of interest relevant to this article.
of Surgery, Taipei Medical University Hospital, Number 252, Wu Hsing Street, Taipei 11031, Taiwan.
edu.tw, hfchien@ntu.edu.tw (H.-F. Chien).
6.01.012
n Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC
mons.org/licenses/by-nc-nd/4.0/).
58 C.-W. Chang et al.only risk factor significantly associated with complications. Clinically, BMI 24 kg/m2, rather
than the standard definition of obesity (BMI > 30 kg/m2), may be a more suitable cutoff point
for risk in patients of Asian ethnicity.
Copyright ª 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Demographic data on breast cancer patients, including
treatment outcomes, show inter-regional differences as
well as ethnic differences within a given region. In partic-
ular, published studies involving breast cancer patients in
Taiwan indicate considerable discrepancy with Caucasian
populations, such as a lower average body mass index (BMI)
of 23.9 kg/m2, a younger average age of onset of
40e50 years, and a lower rate of cigarette smoking of
2e4%, compared to an average BMI of 27.5 kg/m2, age of
onset of 60e70 years, and rate of cigarette smoking of
24e50% in Caucasian populations.1e3
Immediate, two-stage, tissue expander/implant is the
most common method of breast reconstruction.4e6
BMI > 30 kg/m2, hypertension, cigarette smoking, advanced
age, large breast size, large tissue expander size and radio-
therapy are reported to be risk factors associated with
complications in the tissue expander stage.6e14 However,
recent studies based on East Asian and Asian American pop-
ulations indicate that type 2 diabetes and hypertension risk
are significantly greater even among peoplewith a lower BMI,
suggesting that for these populations a more appropriate
definition of at-risk BMI (i.e., obesity) for both diabetes and
cardiovascular disease would be 23e25 kg/m2.15e18
Similarly, it seems reasonable to question whether, in
the case of breast reconstruction surgery, BMI > 30 kg/m2
and other commonly reported risk factors of complications
are appropriate for Asian populations. The above-
mentioned findings for tissue expander breast reconstruc-
tion are based primarily on studies of Caucasian populations
with relatively few studies of Asian populations having been
conducted. In this study, we aimed to survey the risk fac-
tors associated with complications of tissue expander
placement and to investigate the clinical implications for
Taiwanese populations.Methods
Patients who underwent immediate, two-stage, tissue
expander breast reconstruction from December 2008 to
August 2014 in the National Taiwan University Hospital, Tai-
pei, Taiwan were included in this study. Follow-up observa-
tions of all patients were conducted until December 2014.
After mastectomy, all patients underwent smooth,
round tissue expander implantation (Mentor Corp., Santa
Barbara, CA, USA). The expander size was chosen based on
body weight, body height, breast contour, width of chest
wall and resected breast mass. A variable volume of normal
saline (20e100 mL) was injected into the tissue expander asthe pre-expansion volume; the exact amount of which was
determined by skin tension. The pectoralis major muscle
and the serratus anterior muscle were dissected and
elevated to fully cover the tissue expander. We excluded
patients treated with acellular dermal matrix for lower
pole reconstruction. Some patients in this study underwent
additional rectus abdominis muscle dissection to supply
adequate muscle tissue for better tissue expander coverage
and a better defined inframammary fold.
Complications occurring only during the tissue expander
stage were evaluated, including skin necrosis, capsular
contracture, wound dehiscence, infection, implant
rupture, and hematoma. Those complications may result in
unexpected removal of tissue expander. Infection was
defined as inflammatory changes that resulted in treatment
with antibiotics and/or surgical intervention. Capsular
contracture was defined as Baker Scale Grade III and Grade
IV, which would result in early expander loss. Most patient
experienced some degree of capsular contracture in the
late stage. Severe capsular contracture, however, might
share the same risk factors as infection and hematoma.
Patients experiencing any of the above complications were
included in the complication group.
Statistical analysis
Student t test was used to compare continuous data and
Fisher’s exact test was used for categorical data. Risk
factors found to be statistically significant were further
analyzed in the logistic regression model. Two-tailed p
values < 0.05 were considered to be significant. All statis-
tical analyses were performed with SAS version 9.2 (SAS
Institute Inc., Cary, NC, USA).
Ethical approval
The study was approved by the Research Ethics Committee,
National Taiwan University Hospital (Institute Review Board
code 201503024RINC).
Results
From December 2008 to August 2014, 332 patients under-
went immediate breast reconstruction at National Taiwan
University Hospital, including 238 with tissue expander two-
stage reconstruction, 45 with autologous reconstruction, 40
with gel implant reconstruction, and nine with saline
implant reconstruction. Only patients who underwent im-
mediate, two-stage tissue expander implantation were
included in this study. Among 238 patients, eight had
Table 1 Patient characteristics of tissue expander breast
reconstruction.
Characteristic No.
Unilateral; bilateral 230; 8
Total 246
Mean BMI (kg/m2) 22.6  3.2 (16.4e34.9)
Mean age (y) 45.9  8.7 (20e74)
Past history (n Z 238)
Cigarette smoking 8 (3.4)
Diabetes mellitus 10 (4.2)
Hypertension 22 (9.2)
Operation (n Z 246)
Breast mass resected (g) 380.2 (60e995)
Final implant volume (mL) 311.5 (125e600)
Other treatment modality (n Z 238)
Chemotherapy 141 (59.2)
Tamoxifen 142 (59.7)
Aromatase inhibitor 29 (12.2)
Herceptin 40 (16.8)
Radiation therapy 41 (17.2)
Final construction (wDec 2014) 206 (83.7)
Gel implant 202
Gel implant þ LD flap 1
Saline implant 1
Pedicle TRAM flap 2
Time to final reconstruction (d) 211.8 (32e878)
Data are presented as n (%), n (range) or mean  standard
deviation (range).
BMI Z body mass index; LD flap Z latissimus dorsi flap; TRAM
flap Z transverse rectus abdominis myocutaneous flap.
Figure 2 Surgical method. ALND Z axillary lymph node
dissection; MRM Z modified radical mastectomy, simple
mastectomy þ axillary lymph node dissection; PM Z partial
mastectomy; SLND Z sentinel lymph node dissection;
SM Z simple mastectomy.
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constructions were evaluated. The mean age was 45.9 years
and mean BMI was 22.6 kg/m2. Past history and treatment
modality are shown in Table 1. Forty-one patients under-
went radiotherapy in our study, and all of them had uni-
lateral reconstruction. The most common diagnosis for
mastectomy was invasive ductal carcinoma (64.6%) fol-
lowed by ductal carcinoma in situ (25.6%; Figure 1). A
simple mastectomy with sentinel lymph node dissectionFigure 1 Diagnosis of breast tumor. DCISZ ductal carcinoma
in situ; IDC Z invasive ductal carcinoma; ILC Z invasive
lobular carcinoma; LCIS Z lobular carcinoma in situ; other
malignancy:apocrine carcinoma  2, micropapillary
carcinoma  1, mucinous carcinoma  3, phyllodes tumor  4.(67.9%) was performed more than a modified radical mas-
tectomy (29.6%; Figure 2).
Complications occurred in 40 cases (16.3%), which were
all unilateral. Some cases experienced more than one
complication (Table 2). The most common complications
were skin necrosis, which occurred in 12 cases (4.9%), fol-
lowed by wound dehiscence in 10 cases (4.1%) and severe
capsular contracture in nine cases (3.6%). Thirteen tissue
expanders were removed before permanent reconstruc-
tion, including four due to rupture, four to infection, one to
rupture with infection, one to wound dehiscence and three
to chest wall discomfort. All three patients who experi-
enced chest wall discomfort exhibited no other complica-
tions and underwent removal of tissue expander electively.
Six out of the 13 underwent reimplantation of the tissue
expander and four proceeded to permanent reconstruction.
As of December 2014, 206 cases (83.7%) of finished per-
manent breast reconstruction had been performed, con-
sisting of 202 gel implants, two pedicle TRAMs (transverse
rectus abdominis myocutaneous), one gel implant com-
bined with a latissimus dorsi flap, and one saline implant.
The mean period before final reconstruction was 211 days.
In the univariate analysis, the complication group
exhibited trends of larger BMI, more cases of advanced
lymph node stage diagnosed, and higher rates of treatment
with chemotherapy, aromatase inhibitor and radiation
compared to the group that did not experienceTable 2 Complications of tissue expander for breast
reconstruction.
Complication Tissue expander; n Z 246
Skin necrosis 12 (4.9)
Wound dehiscence 10 (4.1)
Capsular contracture 9 (3.6)
Infection 6 (2.4)
Hematoma 3 (1.2)
Implant rupture 5 (2.0)
Removal of tissue expander 13 (5.8)
Re-implant 6
Data are presented as n (%).
Table 4 Multivariable regression of predictors for
complications with tissue expander.
Variable OR 95% CI p
BMI  24 kg/m2 2.41 1.17e4.96 0.0016
Chemotherapy
Nil 1.0 Reference
Adjuvant 1.6 0.64e4.02 0.3132
Neoadjuvant 2.63 0.64e0.77 0.1776
Aromatase inhibitor 2.43 0.97e6.06 0.0576
Radiotherapy 2.27 0.77e6.71 0.137
BMIZbodymass index; CIZ confidence interval; ORZodds ratio.
Table 3 Complication analysis of tissue expanders.
Variables Without complication (n Z 206) Complication (n Z 40)
Mean age (y) 45.66  8.55 47.45  9.21 0.2325
Mean BMI (kg/m2) 22.32  3.06 24.07  3.43 0.0014
Resection mass (g) 369.15  184.39 436.08  194.79 0.053
Expander volume (mL) 448.55  102.14 467.25  106.6 0.2943
Past history
Diabetes mellitus 9 (4.37) 1 (2.5) 1.000
Hypertension 18 (8.74) 4 (10) 0.7646
Cigarette smoking 5 (2.43) 3 (7.5) 0.124
Diagnosis
DCIS 58 (28.16) 5 (12.5)
IDC 127 (61.65) 32 (80)
ILC 11 (5.34) 2 (5)
Other malignancy 10 (4.85) 1 (2.5)
Cancer stage
Tumor size 0.1913
Tis 48 (23.88) 5 (12.5)
T1 82 (40.8) 16 (40)
T2 51 (25.37) 16 (40)
T3 20 (9.95) 3 (7.5)
Lymph node status 0.0033
N0 149 (73.4) 20 (50)
Nþ 54 (26.6) 20 (50)
OP method 0.3485
MRM 58 (28.16) 16 (40)
PM þ SLND 1 (0.49) 0
SM 3 (1.46) 1 (2.5)
SM þ SLND 144 (69.9) 23 (57.5)
Treatment modality
Chemotherapy 0.0158
Nil 89 (43.2) 9 (22.5)
Adjuvant 105 (50.97) 25 (62.5)
Neoadjuvant 12 (5.83) 6 (15)
Tamoxifen 122 (59.22) 25 (62.5) 0.699
Aromatase inhibitor 21 (10.19) 9 (22.5) 0.034
Hercepetin 36 (17.48) 5 (12.5) 0.4397
Radiotherapy 27 (13.11) 14 (35) 0.0007
Data are presented as n (%) or mean  standard deviation.
ALND Z axillary lymph node dissection; DCIS Z ductal carcinoma in situ; IDC Z invasive ductal carcinoma; ILC Z invasive lobular
carcinoma; LCIS Z lobular carcinoma in situ; MRMZ modified radical mastectomy; PMZ partial mastectomy; SLND Z sentinel lymph
node dissection; SM Z simple mastectomy.
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were included in our multivariate analysis, BMI was the only
risk factor that reached statistical significance (Table 4).
BMI 24 kg/m2 (odds ratio: 2.41, 95% confidence interval:
1.17e4.96) is the appropriate cutoff point for risk of
complication in our patients.
Discussion
Diagnosis of female breast cancer has shown a steady yearly
increase worldwide because of early detection by screening
programs. The ageeincidence curves of breast cancer in
Taiwanese and Caucasian populations differ markedly, with
Taiwanese women typically diagnosed between the ages of
40 years and 50 years and Caucasian women between
60 years and 70 years.2 Observational studies indicate that
younger women have a higher reconstruction rate thanolder women and also have higher expectations in terms of
aesthetic outcome.19
When a patient consulted for tissue expander breast
reconstruction, we informed her of the risk factors
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Tissue expander breast reconstruction in Taiwan 61reported in prior studies. However, those factors may not
account for complications in East Asian populations, as the
risk factors of BMI > 30 kg/m2, cigarette smoking, and age
> 55 years are less common than in Caucasian populations.
Differences with respect to the relative effect of risk fac-
tors clearly do exist among different ethnic groups for a
variety of diseases.
Comparative studies have shown that obesity
(BMI > 30 kg/m2) is more highly associated with surgical
morbidity in tissue expander breast reconstruction.20 High
BMI is associated with microvascular dysfunction and may
contribute to reduced perfusion in the mastectomy skin
flap, leading to further complications.21 Although many
articles have reported BMI > 30 kg/m2 to be a risk factor,
such a high BMI is less common in East Asian populations.
The mean BMI of breast cancer patients in East Asia is
22.7e25.0 kg/m2 22e25 and is 22.9e23.9 kg/m2 in the Asian
American population,1,20,26 compared with 26.8e27.1 kg/
m2 in Caucasian population.14,27 In our study, the mean BMI
was 22.6 kg/m2 and only five (2.1%) of 238 patients had a
BMI > 30 kg/m2. The low prevalence of obesity
(BMI > 30 kg/m2) in these populations may alter the rela-
tive effect of the risk factors identified in previous studies
based on Caucasian populations.
In the multivariate analysis, BMI was the only risk factor
identified in our study as significantly associated with
complications in tissue expander breast reconstruction.
Patients who experienced complications during the tissue
expander placement stage had higher BMI (24.07 kg/m2)
than patients who did not (22.32 kg/m2), but the mean BMI
of both groups was < 30 kg/m2. This suggests that patients
in our Taiwanese population need not be obese to experi-
ence complications associated with tissue expander
placement.
Similar results have also been observed in risk for type 2
diabetes and cardiovascular disease in the greater East
Asian population and among Asian Americans. Although
Asian Americans had a lower prevalence of obesity (w10%)
compared with the entire US population (w35%), diabetes
risk in Asia Americans has increased with BMI significantly
lower than usual defined figure of 30 kg/m2.15 This paradox
may explain why East Asian people have more body fat than
white people with the same BMI, which is closely associated
with insulin resistance. Therefore, the optimal BMI cutoff
point to screen diabetes and even the definition of obesity
in East Asians and Asian Americans should be redefined
between 22 kg/m2 and 25 kg/m2.16e18 Although high BMI
was a risk factor for diabetes and complications of breast
reconstruction, diabetes itself was not a risk factor for
complications of breast reconstruction. Our study had
similar results to previous studies.6e8,28
Currently, when a patient consults for tissue expander
breast reconstruction in Taiwan, the standard protocol is to
inform them of the currently recognized risk factors, such
as BMI > 30 kg/m2, since no other standards exist that
might be more appropriate for the population of Taiwan,
China, or Japan. Yet, in practice, treatment decisions are
based on different measures of risk, such as a BMI cutoff
well below 30 kg/m2. Our findings suggest that BMI 24 kg/
m2 (odds ratio: 2.41, 95% confidence interval: 1.17e4.96) is
the appropriate cutoff point for risk of complications in our
patients. Since the average BMI of breast cancer patients ofAsian American ethnicity is also around 24 kg/m2, this may
also be a more appropriate cutoff point of BMI as a risk
factor for Asian Americans.1,20 Confirmation of this hy-
pothesis requires more data based on Asian American
populations.
Radiotherapy is a well-documented risk factor for
implant complications and failure in breast reconstruc-
tion.29,30 The optimal timing and sequence of radiotherapy,
chemotherapy, mastectomy, and final reconstruction is still
unclear.28 Some studies have reported relatively low
complication and failure rates when radiation was per-
formed after permanent reconstruction.31e33 In these
studies, patients who underwent radiotherapy after per-
manent reconstruction may experience a longer post-
mastectomy treatment duration than patients who under-
went radiotherapy during the expander stage. However,
Lentz et al34 reported no difference in overall complication
or failure rates between patients who underwent final
reconstruction before or after radiotherapy. We believe
that achievement of stable perfusion in the post-
mastectomy skin flap, rather than the properties of the
gel implant or tissue expander itself, was the main reason
for this favorable outcome.
We preferred to wait to perform the permanent recon-
struction until after all other treatment modalities were
completed for two reasons. First, most of our patients had
early breast cancer so that treating them in accordance
with National Comprehensive Cancer Network guidelines by
providing timely administration of radiotherapy and
chemotherapy is important.35 Second, because our patients
were younger, aesthetic results were also considered of
great importance, and prior studies suggest that performing
permanent reconstruction after radiotherapy allows for
improved aesthetic outcomes.
Before 2014, complications were reported in 11 of our
patients who received radiotherapy. Nine of the 11 patients
experienced complications after radiotherapy, and two
cases had complications before radiotherapy, which was
not related. The mean period from termination of radio-
therapy to onset of a complication was 161.3 days. Com-
plications resulted in the removal of six tissue expanders
and one final gel implant. Although the result was not sig-
nificant (p Z 0.15, Table 5), we adjusted our standard
protocol after 2014 for patients expected to undergo
radiotherapy by postponing permanent reconstruction
around 6 months after completion of radiotherapy. This
may be due to the small number of cases. Delay of per-
manent reconstruction was not intended to reverse the
harmful effect of radiation. Instead, we allowed ample
time for modification and stabilization of skin perfusion, in
an effort to avoid any loss of permanent gel implants. Since
capsular contracture will inevitably develop with time, the
62 C.-W. Chang et al.tissue expander should be filled with the desired volume or
slightly higher to counteract the contracture caused by
radiation scarring. We did not opt for a partially inflated
tissue expander for radiation since scar tissue was difficult
to expand and had poor perfusion.12,36 Final reconstruction
with capsulotomy or capsulectomy was performed after all
other treatment modalities were completed. Because of
this postponement protocol, mean interval from mastec-
tomy to final reconstruction was 211.8 days, which was
considerably longer than the mean period reported in prior
studies.
There were several limitations to this study arising from
its retrospective nature. Our study indicated that
BMI 24 kg/m2 was the main risk factor associated with all
complications in the tissue expander placement stage in
the Taiwanese population. More comparative studies across
countries are needed to determine whether this cutoff
point is similar in other East Asian populations, such as in
Japan, Korea, and China. In addition, we believe that
smoking compromised skin circulation and increased the
complication rate. Only 3.4% of patients, however, in our
study reported cigarette smoking, far less than the 13.4%
reported in the US.26 Statistical power may have been
inadequate to detect the importance of this risk factor
because of the low prevalence rate of smokers. Finally, we
performed the permanent reconstruction after a delay with
the intention of preventing complications in the permanent
implant phase in order to achieve better cosmetic results.
Therefore, no control group of patients who underwent
radiotherapy in the permanent implant stage was available
to investigate the impact of when radiotherapy occurred. A
prospective study is required to guide the balance between
radiotherapy and reconstruction.
Conclusion
Ethnic differences in breast-cancer-specific survival are
well documented. Our study provides evidence of ethnic
differences in breast cancer patients who underwent im-
mediate two-stage tissue expander reconstruction in
Taiwan, adding to the existing literature. Lower prevalence
rates of obesity, smoking, and diabetes, as well as a
younger age of onset, distinguish our results from prior
reports. BMI 24 kg/m2 was the only risk factor associated
with all complications of expander-based reconstruction,
with a cutoff point falling below the usual definition of
obesity. This finding also agrees with the recently estab-
lished at-risk BMI cutoff point for risk of type 2 diabetes,
cardiovascular disease and obesity in the East Asian popu-
lation and among Asian Americans. Our study also suggests
that final breast reconstruction in patients designated to
undergo radiotherapy should be delayed to prevent com-
plications associated with permanent implant.
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